Gamida Cell - Cord Blood Transplant

Latest News

Enhancing the Power of Stem Cell Therapy

Gamida Cell is a world leader in stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. The company’s pipeline of stem cell therapy products, derived from non-controversial sources such as umbilical cord blood, are in development to treat a wide range of conditions including blood cancers such as leukemia and lymphoma, solid tumors, autoimmune diseases, non-malignant hematological diseases such as sickle cell disease and thalassemia, Neutropenia, acute radiation syndrome and metabolic diseases.

StemEx® – Gamida Cell’s First Stem Cell Therapy Product

The company’s lead stem cell therapy product, StemEx, has completed an international, Phase II/III clinical trial. StemEx is an alternative, experimental treatment to a bone marrow transplant, for blood cancer patients who cannot find a matched related bone marrow donor.

Pipeline Products

To learn more about our products and clinical trials, please fill in:
* Message:
* Please type in the verification code as appears on the image: